Folgen
Kenneth A. Jacobson
Kenneth A. Jacobson
National Institutes of Health
Bestätigte E-Mail-Adresse bei niddk.nih.gov - Startseite
Titel
Zitiert von
Zitiert von
Jahr
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
BB Fredholm, AP IJzerman, KA Jacobson, KN Klotz, J Linden
Pharmacological reviews 53 (4), 527-552, 2001
35362001
VI. Nomenclature and classification of purinoceptors
BB Fredholm, MP Abbracchio, G Burnstock, JW Daly, KT Harden, ...
Pharmacological reviews 46 (2), 143, 1994
20841994
Adenosine receptors as therapeutic targets
KA Jacobson, ZG Gao
Nature reviews Drug discovery 5 (3), 247-264, 2006
17822006
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update
BB Fredholm, AP IJzerman, KA Jacobson, J Linden, CE Müller
Pharmacological reviews 63 (1), 1-34, 2011
16352011
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy
MP Abbracchio, G Burnstock, JM Boeynaems, EA Barnard, JL Boyer, ...
Pharmacological reviews 58 (3), 281-341, 2006
16312006
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 178, S27-S156, 2021
13052021
Structure of an agonist-bound human A2A adenosine receptor
F Xu, H Wu, V Katritch, GW Han, KA Jacobson, ZG Gao, V Cherezov, ...
Science 332 (6027), 322-327, 2011
9552011
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
S Koizumi, Y Shigemoto-Mogami, K Nasu-Tada, Y Shinozaki, K Ohsawa, ...
Nature 446 (7139), 1091-1095, 2007
9392007
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential
KA Jacobson, PJM Van Galen, M Williams
Journal of medicinal chemistry 35 (3), 407-422, 1992
6791992
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors
HK Eltzschig, JC Ibla, GT Furuta, MO Leonard, KA Jacobson, K Enjyoji, ...
The Journal of experimental medicine 198 (5), 783-796, 2003
6052003
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
MP Abbracchio, JM Boeynaems, EA Barnard, JL Boyer, C Kennedy, ...
Trends in pharmacological sciences 24 (2), 52-55, 2003
5702003
Recent developments in adenosine receptor ligands and their potential as novel drugs
CE Müller, KA Jacobson
Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1290-1308, 2011
5252011
Towards a revised nomenclature for P1 and P2 receptors
BB Fredholm, MP Abbracchio, G Burnstock, GR Dubyak, TK Harden, ...
Trends in pharmacological sciences 18 (3), 79, 1997
4721997
Structure of the human P2Y12 receptor in complex with an antithrombotic drug
K Zhang, J Zhang, ZG Gao, D Zhang, L Zhu, GW Han, SM Moss, ...
Nature 509 (7498), 115-118, 2014
4692014
Purine and pyrimidine (P2) receptors as drug targets
KA Jacobson, MF Jarvis, M Williams
Journal of medicinal chemistry 45 (19), 4057-4093, 2002
4182002
Two disparate ligand-binding sites in the human P2Y1 receptor
D Zhang, ZG Gao, K Zhang, E Kiselev, S Crane, J Wang, S Paoletta, C Yi, ...
Nature 520 (7547), 317-321, 2015
4062015
Agonist-bound structure of the human P2Y12 receptor
J Zhang, K Zhang, ZG Gao, S Paoletta, D Zhang, GW Han, T Li, L Ma, ...
Nature 509 (7498), 119-122, 2014
3822014
Adenosine A3 receptors: novel ligands and paradoxical effects
KA Jacobson
Trends in pharmacological sciences 19 (5), 184-191, 1998
3781998
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
3722017
Adenosine A3 receptor stimulation and cerebral ischemia
DKJE Von Lubitz, RCS Lin, P Popik, MF Carter, KA Jacobson
European journal of pharmacology 263 (1-2), 59-67, 1994
3481994
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20